PROLONGED SURVIVAL IS ACHIEVABLE FOR A QUARTER OF PATIENTS IN PRIMARY INDUCTION FAILURE FOR ACUTE MYELOID LEUKEMIA, BUT DOES NOT RELY ON REPEATED SALVAGE THERAPY – A MONOCENTRIC RETROSPECTIVE STUDY

EHA Library, Marie-Pierre Ledoux, 132463

IMPACT OF SINGLE NUCLEOTIDE POLYMORPHISMS OF ABCB1 GENE UPON THE EFFECTIVENESS AND TOXICITY OF INDUCTION CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Juan Eduardo Megías-Vericat, 132464

CLEARANCE OF NPM1 MUTATION AT FIRST COMPLETE REMISSION AFTER INDUCTION THERAPY DID NOT PREDICT THE SURVIVAL IN FAVORABLE RISK GROUP WITH NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA

EHA Library, Seung-Shin Lee, 132465

VALIDATING THE PATIENT'S 'FITNESS' CRITERIA PROPOSED TO GUIDE TREATMENT DECISION IN ELDERLY AML : A MULTICENTER STUDY ON A SERIES OF 699 PATIENTS BY THE NETWORK 'RETE EMATOLOGICA LOMBARDA'

EHA Library, Chiara Pagani, 132466

CLINICAL CHARACTERISTICS AND OUTCOME OF PEDIATRIC ACUTE MYELOID LEUKEMIA WITH DEL(5Q) : A REPORT FROM THE JAPANESE PEDIATRIC LEUKEMIA/LYMPHOMA STUDY GROUP.

EHA Library, Akitoshi Kinoshita, 132467

DOSE ESCALATION STUDY OF CRENOLANIB IN COMBINATION WITH HIGH DOSE CYTARABINE/IDARUBICIN SALVAGE CHEMOTHERAPY IN MULTIPLY RELAPSED FLT3 POSITIVE AML

EHA Library, Jorge Cortes, 132468

QUANTIFICATION OF COMMON AND RARE NPM1 SUBTYPES USING A SINGLE MASSIVELY MULTIPLEX DIGITAL PCR ASSAY FOR MINIMAL RESIDUAL DISEASE IN AML

EHA Library, Nuria Mencia Trinchant, 132469

A SIMPLE 3-GENE MOLECULAR SCORE RETAINS HIGH PROGNOSTIC VALUE IN NON HIGH RISK ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH AIDA 2000 PROTOCOL: A RETROSPECTIVE STUDY FROM A REGIONAL REGISTER

EHA Library, Daniela Guardo, 132470

ACUTE MYELOID LEUKEMIA (AML) IN ELDERLY PATIENTS (≥70 YRS): SEMI-INTENSIVE INDUCTION AND CONSOLIDATION WITH MAINTENANCE TREATMENT (1-YR) IN OUTPATIENT BASIS

EHA Library, Susana Vives Polo, 132471

COMBINATION OF RNA- AND EXOME-SEQUENCING EFFICIENTLY ELIMINATES FALSE-POSITIVE SOMATIC POINT MUTATIONS AND INDELS – EXEMPLIFIED BY CASES OF CN-AML

EHA Library, Marcus Hansen, 132472

A BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM-LIKE PHENOTYPE IDENTIFIES A SUBGROUP OF NPM1-MUTATED AML PATIENTS WITH WORSE PROGNOSIS

EHA Library, Paola Minetto, 132473

MFC -MRD ASSESSMENT MAY DRIVE POST INDUCTION CONSOLIDATION IN INTERMEDIATE RISK AML . IS IT TIME FOR MRD-DRIVEN DECISION MAKING?

EHA Library, Paola Minetto, 132474

ZYGODACTYLY IS STRONGLY ASSOCIATED WITH ACUTE MYELOID LEUKAEMIA

EHA Library, Aaron Niblock, 132476

CLINICAL DECISION SUPPORT SYSTEM (CDSS) BASED ON PATHWAYS-CONSTRAINED SOMATIC MUTATIONAL DATA INTEGRATION IN ACUTE MYELOID LEUKEMIA PERSONALIZED MEDICINE

EHA Library, Marco Manfrini, 132477

MOLECULAR RESPONSE IN ACUTE MYELOID LEUKEMIA WITH WT1 OVEREXPRESSION HAS A STRONG PROGNOSTIC IMPACT IN PATIENS TREATED WITH CHEMOTHERAPY ONLY AND/OR UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Cyril Salek, 132478

CHARACTERIZATION OF PATIENTS WITH RELAPSED OR REFRACTORY AML IN CONTINUED FOLLOW-UP AFTER TREATMENT WITH VOSAROXIN/CYTARABINE VS PLACEBO/CYTARABINE IN THE VALOR TRIAL

EHA Library, Arnaud Pigneux, 132479

DETECTION OF BASOPHIL-ASSOCIATED IMMUNOPHENOTYPIC FEATURES OF ACUTE PROMYELOCYTIC LEUKEMIA BLAST CELLS AT DIAGNOSIS IS ASSOCIATED TO A HIGHER AND MORE SEVERE BLEEDING DIATHESIS

EHA Library, Alberto Orfao, 132480

ASSESSMENT OF BAALC AND MN1 GENE EXPRESSION LEVEL COULD CONTRIBUTE TO IMPROVED PROGNOSTIC STRATIFICATION OF THE AML-NK PATIENTS

EHA Library, Irena Marjanovic, 132481

ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA AND NORMAL KARYOTYPE HAVE A FAVOURABLE OUTCOME AFTER INTENSIVE THERAPEUTIC PROGRAMS

EHA Library, massimo bernardi, 132482

THE HOMOZYGOUS TP53 P72R SNP IS ASSOCIATED WITH NON-FAVORABLE CYTOGENETIC RISK GROUPS IN ACUTE MYELOID LEUKEMIA

EHA Library, Eduard Schulz, 132483

FLAG-IDA REGIMEN AS SALVAGE THERAPY IN REFRACTORY/RELAPSED AML PATIENTS: A SINGLE-CENTER EXPERIENCE

EHA Library, Mario Delia, 132484

DECITABINE COMBINED WITH HAAG AS INDUCTION CHEMOTHERAPY FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Xiaowen Tang, 132485

AGE FACTOR ON REMISSION INDUCTION THERAPY FOR ADULT ACUTE MYELOID LEUKEMIA

EHA Library, Hawk Kim, 132486

DEFINING FRAILTY OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA AT DIAGNOSIS

EHA Library, Ernesta Audisio, 132487

GENOTYPIC AND PHENOTYPIC CLONAL EVOLUTION IN RELAPSED FAVORABLE-ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Carmen Martinez Losada, 132488

DNMT3A MUTATIONS IN ACUTE MYELOID LEUKAEMIA WITH INTERMEDIATE-RISK KARYOTYPE - INCIDENCE AND CORRLEATION WITH OTHER GENE MUTATIONS

EHA Library, Gee Fung How, 132489

CLINICAL CHARACTERISTICS OF ACUTE MYELOID LEUKEMIA PATIENTS FROM REGIONS CONTAMINATED BY DEPLETED URANIUM: 20 YEAR ANALYSIS

EHA Library, Amina Kurtovic-Kozaric, 132490

COMPARISON OF AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION TO INTENSIVE CONSOLIDATION CHEMOTHERAPY AND MONITORING MINIMAL RESIDUAL DISEASE IN CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA

EHA Library, Hee Kyung Kim, 132491

PROGNOSTIC IMPLICATIONS OF THE IDH1 SINGLE NUCLEOTIDE POLYMORPHISM RS11554137 IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Irina Martynkevich, 132492

OUTCOMES WITH RITUXIMAB MONOTHERAPY VERSUS R-CHOP IN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE ARISING AFTER SOLID ORGAN TRANSPLANT: A UNITED KINGDOM MULTICENTRE STUDY

EHA Library, David Burns, 132493

EXTRANODAL NK/T-CELL LYMPHOMA, NASAL TYPE OF ADVANCED STAGE: NKEA (NEXT-GENERATION THERAPY FOR NK/T-CELL LYMPHOMA IN EAST ASIA) PROJECT.

EHA Library, Ritsuro Suzuki, 132494

VALIDATION OF NCCN INTERNATIONAL PROGNOSTIC INDEX (NCCN-IPI) FOR DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL). THE ADDITION OF Β2MICROGLOBULIN RESULTED IN GELTAMO-IPI THAT IS MORE ACCURATE.

EHA Library, Carlos Montalban, 132495

EVALUATION OF A PROGNOSTIC MODEL FOR CNS RELAPSE WITHIN THE UK NCRI R-CHOP-14 VS 21 TRIAL

EHA Library, Gleeson Mary, 132496

SAFETY AND CLINICAL ACTIVITY OF TEMSIROLIMUS IN COMBINATION WITH RITUXIMAB AND DHAP IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA – PRELIMINARY RESULTS OF THE STORM TRIAL

EHA Library, Mathias Witzens-Harig, 132497

PROGNOSTIC FACTORS IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL) AFTER RITUXIMAB-CHOP (R-CHOP) WITH OR WITHOUT RADIOTHERAPY (RT): MATURE RESULTS OF A COOPERATIVE RETROSPECTIVE STUDY

EHA Library, Theodoros Vassilakopoulos, 132499

A POOLED DATA ANALYSIS OF TWELVE CLINICAL TRIALS OF FONDAZIONE ITALIANA LINFOMI (FIL): KHORANA SCORE AND HISTOTYPE PREDICT THE INCIDENCE OF EARLY VENOUS THROMBOEMBOLISM (VTE) IN NON HODGKIN LYMPHOMA

EHA Library, Roberto Santi, 132500

HEMOGLOBIN LEVEL IMPROVES THE ABILITY OF THE NATIONAL COMPREHENSIVE CANCER NETWORK INTERNATIONAL PROGNOSTIC INDEX TO PREDICT OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA - A POPULATION BASED COHORT STUDY.

EHA Library, Michael Clausen, 132501

ROUTINE IMAGING FOR PERIPHERAL T-CELL LYMPHOMA IN FIRST COMPLETE REMISSION DOES NOT IMPROVE SURVIVAL: A DANISH-SWEDISH POPULATION-BASED STUDY

EHA Library, Henrik Cederleuf, 132502

REAL-TIME CELL-OF-ORIGIN SUBTYPE IDENTIFICATION BY GENE EXPRESSION PROFILE IN THE PHASE 3 ROBUST TRIAL OF LENALIDOMIDE + R-CHOP VS PLACEBO + R-CHOP IN PREVIOUSLY UNTREATED ABC-TYPE DLBCL

EHA Library, Umberto Vitolo, 132503

MYD88 (L265P) MUTATION IS ASSOCIATED WITH AN UNFAVORABLE OUTCOME OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Keiichiro Hattori, 132504

SUBCUTANEOUS VERSUS INTRAVENOUS RITUXIMAB ADMINISTRATION IN FIRST-LINE DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA: PREFMAB STUDY OF PATIENT PREFERENCE AND SATISFACTION IN 19 COUNTRIES

EHA Library, Mathias Rummel, 132505

EXTRACORPOREAL PHOTOPHERESIS: SAFE AND EFFECTIVE FOR THE TREATMENT OF MYCOSIS FUNGOIDES

EHA Library, Erden Atilla, 132506

R-DA-EPOCH WITHOUT RADIOTHERAPY IN PRIMARY MEDIASTINAL LYMPHOMA PATIENTS RESULTS IN SIMILAR OUTCOME IN COMPARISON WITH A HISTORICAL COHORT TREATED WITH RADIOTHERAPY BASED REGIMENS.

EHA Library, Anna Guidetti, 132507

COMPARISON OF BONE MARROW ASPIRATE FLOW CYTOMETRY AND TREPHINE IMMUNOHISTOCHEMISTRY IN STAGING OF PATIENTS WITH LYMPHOMA.

EHA Library, Gulnaz Shah, 132508

EVALUATION OF THE NEW PROGNOSTIC SCORE IN HIV RELATED NON HODGKIN LYMPHOMA. EXPERIENCE IN UNIVERSITY HOSPITAL SON ESPASES.

EHA Library, Silvia Ruiz De Gracia, 132509

SERUM IL-10 LEVEL PREDICTS POOR PROGNOSIS IN PATIENTS WITH ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: RESULTS OF A SINGLE CENTER COHORT STUDY

EHA Library, Seok Jin Kim, 132510

REDUCED RCHOP FOR ELDERLY PATIENTS WITH DLBCL

EHA Library, Liat Vidal, 132511

A PREDICTIVE SCORE FOR CNS DISSEMINATION AND ITS EFFECT ON CNS PROPHYLAXIS IN A MONO-INSTITUTIONAL SERIES OF 242 PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED IN THE RITUXIMAB ERA

EHA Library, Andres Jose Maria Ferreri, 132512

A PHASE I STUDY IN T CELL LYMPHOMA PATIENTS TREATED WITH ANTI-CD70 SIMPLE ANTIBODY™ ARGX-110

EHA Library, Jean-Marie Michot, 132513

DOUBLE PROTEIN LYMPHOMA PATIENTS OF THE NON-GCB SUBTYPE HAVE AN INFERIOR PROGNOSIS WHEN TREATED WITH CHEMOIMMUNOTHERAPY

EHA Library, Katharina Troppan, 132514

A CLINICO-PATHOLOGIC AND IMMUNOHISTOCHEMICAL ANALYSIS OF ORAL AND EXTRA-ORAL PLASMABLASTIC LYMPHOMA IN SOUTH AFRICA

EHA Library, Shabnum Meer, 132515

A NGS IGK ASSAY FOR THE DETECTION OF CLONALITY AND THE MONITORING OF MINIMAL RESIDUAL DISEASE

EHA Library, Zhiyi Xie, 132516

DE NOVO TRANSFORMED FOLICULAR LYMPHOMA. OUTCOMES AND ROLE OF AUTOLOGOUS STEM CELL TRANSPLANTATION

EHA Library, Miguel Alcoceba, 132517

LOW EXPRESSION OF MIR-155 IN VINCRISTINE RESISTANT DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Hanne Due, 132518

RITUXIMAB AND HIGH DOSE CYTARABINE WITH AUTOLOGOUS TRANSPLANTATION FOR MANTLE CELL LYMPHOMA

EHA Library, Samuel Howard Burrows, 132519

TREATMENT OF INITIAL CENTRAL NERVOUS SYSTEM INVOLVEMENT IN SYSTEMIC AGGRESSIVE LYMPHOMA WITH HIGH DOSE METHOTREXATE AND R-CHOP

EHA Library, Marcel Nijland, 132520

FEASIBILITY AND EFFICACY OF DHAOX REGIMEN AS SALVAGE AND MOBILIZING THERAPY IN RELAPSED /REFRACTORY LYMPHOMAS.

EHA Library, Elisa Coviello, 132521

OUTCOMES OF 34 PRIMARY BREAST DIFFUSE LARGE B-CELL LYMPHOMA IN RITUXIMAB ERA AT A SINGLE INSTITUTION

EHA Library, Noriko Nishimura, 132523

PATIENTS WITH PRIMARY CNS LYMPHOMA OR PRIMARY TESTICULAR DIFFUSE LARGE B-CELL LYMPHOMA HAVE AN INFERIOR PROGNOSIS WHEN CO-EXPRESSING C-MYC AND BCL2.

EHA Library, Katharina Troppan, 132524

CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT IN DIFFUSE LARGE B-CELL LYMPHOMA. A SINGLE CENTER ANALYSIS OF THE RISK FACTORS AND THE IMPACT OF CNS PROPHYLAXIS IN THE RITUXIMAB ERA

EHA Library, Michela Ansuinelli, 132525

SURVIVAL IMPACT OF SERUM ALBUMIN (SA) IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) RELATED NON-HODGKIN’S LYMPHOMAS

EHA Library, Joseph Clara, 132526

OUTCOME FOR PATIENTS WITH RELAPSED/REFRACTORY LYMPHOMA TREATED WITH GEMCITABINE AND OXALIPLATIN WITH OR WITHOUT RITUXIMAB

EHA Library, Vijayavalli Dhanapal, 132527

DOSE-ADJUSTED ETOPOSIDE-PREDNISONE-VINCRISTINE-CYCLOPHOSPHAMIDE-DOXORUBICIN-RITUXIMAB (DA-EPOCH-R) FOR PRIMARY MEDIASTINAL B-CELL LYMPHOMA (PMBCL) AND OTHER VERY HIGH-RISK OR ADVANCED LYMPHOMAS

EHA Library, Francesca Carobolante, 132528

ELDERLY AGE IS NOT EXCLUSION FACTOR FOR INTENSIVE THERAPY BY SCHEME R-DA-EPOCH/R-HMA FOR PATIENTS WITH UNTREATED HIGH-GRADE DIFFUSE LARGE B-CELL LYMPHOMA.

EHA Library, Olga Aleshina Gavrilina, 132529

FREQUENCY AND CLINICAL IMPLICATIONS OF SOX11 EXPRESSION IN BURKITT LYMPHOMA

EHA Library, Tove Wästerlid, 132530

LONG-TERM FOLLOW-UP OF PRIMARY GASTRIC DIFFUSE LARGE B-CELL LYMPHOMATREATED WITH MNHL-BFM-90

EHA Library, Eugeni Zvonkov, 132531

PRIMARY BONE MARROW LYMPHOMA: A HEMATOLOGICAL EMERGENCY IN ADULTS WITH FEVER OF UNKNOWN ORIGIN

EHA Library, Hao Yuan Wang, 132532

CHEMOTHERAPY OF 40 PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATIENTS

EHA Library, Yana MANGASAROVA, 132533

VITREORETINAL LYMPHOMA: A DESCRIPTIVE STUDY OF A VERY RARE OCCURRENCE FROM A SINGLE INSTITUTION IN ITALY.

EHA Library, Angela Ferrari, 132534

R-CHOP VS CHOP IN DIFFUSE LARGE CELL AND FOLLICULAR LYMPHOMAS. EPIDEMIOLOGICAL DATA OF PATIENTS WITH LYMPHOMAS TREATED IN CARACAS (VENEZUELA) FOR 14 YEARS

EHA Library, Aixa Muller Soyano, 132535

IS THAT MALE GENDER AN ADVERSE RISK FACTOR ONLY IN YOUNG PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA ?

EHA Library, Talbi Faiza, 132536

INCIDENTAL FINDINGS BY TARGETED EXOME SEQUENCING USED TO DIAGNOSE RARE INHERITED BLEEDING DISORDERS – PATIENT`S CHOICES ON INFORMATION AND OUTCOME.

EHA Library, Eva Leinoe, 132537

HEMORRHAGIC EVENTS AND PRIMARY HEMOSTASIS DISORDERS DURING TREATMENT WITH IBRUTINIB.

EHA Library, Beatriz Aguado Bueno, 132538

REGULATION OF CD72 EXPRESSION ON CD19+CD27+ MEMORY B CELL BY CD40L IN PRIMARY IMMUNE THROMBOCYTOPENIA

EHA Library, Mingen Lyu, 132539

THROMBIN GENERATION AND WHOLE BLOOD VISCOELASTIC ASSAYS IN THE MONITORING OF HAEMOPHILIA WITH INHIBITORS

EHA Library, Margit Serban, 132540

ACQUIRED HAEMOPHILIA: A MALAYSIAN OUTLOOK

EHA Library, Veena Selvaratnam, 132541

CONTRIBUTION OF HEMODILUTION, FIBRINOLYSIS, ACIDOSIS, AND HYPOTHERMIA TO DERANGEMENT OF CLOT FORMATION IN THE IN VITRO MODEL OF TRAUMA-INDUCED COAGULOPATHY

EHA Library, Ivan Budnik, 132542

DIRECT ORAL ANTICOAGULANTS THERAPY AFTER INTRACRANIAL HAEMORRHAGE WHILE ON VITAMIN K ANTAGONISTS

EHA Library, Amaya Zabalza, 132543

BEVACIZUMAB AS TREATMENT IN REFRACTORY HEREDITARY HAEMORRHAGIC TELANGIECTASIA

EHA Library, Erwing Castillo, 132544

PREDICTION OF INHIBITORS IN UKRAINIAN HAEMOPHILIA PATIENTS

EHA Library, Oleksandra Stasyshyn, 132545

ACQUIRED ISOLATED PROTHROMBIN DEFICIENY IN A PATIENT WITH FOLLICULAR LYMPHOMA SUCCESSFULLY TREATED WITH IMMUNOCHEMOTHERAPY.

EHA Library, Karsten Müller, 132546

THE BLEEDING SPECTRUM OF 21 EGYPTIAN PATIENTS SUFFERING FROM CONGENITAL AFIBRINOGENAEMIA: A 10-YEAR RETROSPECTIVE STUDY

EHA Library, Magy Abdelwahab, 132547

HEALTH RELATED QUALITY OF LIFE IN GREEK CHILDREN WITH HAEMOPHILIA AND THEIR CAREGIVERS.

EHA Library, Andromachi Papagianni, 132548

ANTIPHOSPHOLIPID ANTIBODIES IN PATIENTS WITH IMMUNE THROMBOCYTOPENIC PURPURA

EHA Library, Umran Caliskan, 132549

FUNCTIONAL PLATELET ACTIVITY ANALYSIS IN CHILDREN WITH BLEEDING.

EHA Library, Pavel Zharkov, 132550

SAFETY AND EFFICACY OF B-DOMAIN DELETED 3RD GENERATION RECOMBINANT FACTOR VIII (GREENGENE FTM) IN KOREAN PATIENTS WITH HAEMOPHILIA A: DATA FROM A POST-MARKETING SURVEILLANCE STUDY

EHA Library, Soon Ki Kim, 132551

FACTOR XI DEFICIENCY IN PREGNANCY: THREE CASE REPORTS

EHA Library, Giovanni Barillari, 132552

SERUM CYTOKINE AND CHEMOKINE LEVELS IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA

EHA Library, Anna KOMITOPOULOU, 132553

FALSE HOMOZYGOUS HLA GENOTYPING RESULTS DUE TO LOSS OF HETEROZYGOSITY IN ACQUIRED APLASTIC ANAEMIA.

EHA Library, Bert Heyrman, 132554

PREVALANCE OF CHROMOSALLY-INTEGRATED HERPESVIRUS 6 IN PATIENTS WITH APLASTIC ANEMIA.

EHA Library, Martijn Bakker, 132555

PROSPECTIVE MULTICENTRIC EVALUATION OF THE CURRENT MEDICAL INDICATION FOR PAROXYSMAL NOCTURAL HEMOGLOBINURIA DIAGNOSTIC SCREENING

EHA Library, Alberto Orfao, 132556

POSSIBLE RISK FACTORS FOR THROMBOSIS IN CHINESE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, zhangbiao long, 132557

POLYMORPHISM OF THE COMPLEMENT RECEPTOR 1 GENE IN CHINESE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Bing Han, 132558

EPIDEMIOLOGIC OVERVIEW OF CONGENITAL DYSERYTHROPOIETIC ANEMIA – UPDATED DATA FROM THE GERMAN CDA REGISTRY

EHA Library, Martin Bommer, 132559

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) SCREENING IN PATIENTS WITH UNEXPLAINED ANEMIA: A SINGLE INSTITUTION EXPERIENCE

EHA Library, James England, 132560

EFFICACY AND SAFETY OF DEFIBROTIDE FOR TREATMENT OF HEPATIC VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) IN ADULT AND PEDIATRIC PATIENTS FOLLOWING CHEMOTHERAPY

EHA Library, PAUL RICHARDSON, 132561

THE PI3K DELTA SELECTIVE INHIBITOR, IDELALISIB, MODULATES CYTOKINE PRODUCTION IN INNATE IMMUNE CELLS STIMULATED THROUGH TOLL-LIKE RECEPTORS

EHA Library, Stacey Tannheimer, 132562

MUTATIONS IN SF3B1 GENE ARE SELECTED INDEPENDENTLY ON ATM/TP53 STATUS AND REDUCE THE TIME TO FIRST TREATMENT IN CLL PATIENTS

EHA Library, Michaela Spunarova, 132563

BIOLOGICAL AND CLINICAL FEATURES OF IMMUNOSUPPRESSIVE THERAPY IN PATIENTS AFFECTED BY LARGE GRANULAR LYMPHOCYTE LEUKEMIA

EHA Library, Antonella Teramo, 132564

CD49D IS A BETTER PREDICTOR OF OVERALL SURVIVAL THAN THE NOVEL RECURRENT MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS FROM AN ITALIAN MULTI-CENTER COHORT

EHA Library, Valter Gattei, 132565